What is cagrilintide?
A long-lasting, lab-made relative of the hormone amylin. It is being studied for weight management.
Is CagriSema the same thing?
No. CagriSema combines cagrilintide with semaglutide.
Is either one approved in the United States?
No, as of September 2026.
Can a compounding pharmacy make cagrilintide?
No. The FDA says federal law does not allow it.
Where does legitimate access exist now?
In registered clinical trials. ClinicalTrials.gov, the government-run public list of studies, showed several with U.S. locations in September 2026.
Did the main trial show weight loss?
Yes. The combination produced a large average loss, but the result belongs to CagriSema, not cagrilintide alone.
What was the common problem in trials?
Stomach trouble was common, especially nausea, vomiting, and constipation.
What is the official price?
There is none yet because no approved product is on sale.
What is the clearest red flag?
An offer to sell a prescription medicine without a prescription, or a research vial sold as if it were care.
Chapter recap
A doctor’s visit may discuss approved choices. For cagrilintide itself, check whether an offer is a registered study or an unapproved sale.